Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 30,500 shares at $1.45 ($44K) on 2022-02-10, disclosed to the SEC on 2022-02-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.45 | 23,500 | $34K | 76.8% |
| 2 | $1.45 | 3,000 | $4K | 9.8% |
| 3 | $1.49 | 4,000 | $6K | 13.4% |
| Total | $1.46 avg | 30,500 | $44K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |